The global Ultomiris Drug Market is entering a high-growth phase, supported by rising demand for advanced therapies for rare and life-threatening disorders, expanding clinical applications, and the growing preference for longer-acting complement inhibitors. According to M2Square Consultancy, the market is projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033,...